Figure 4 — Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy | Aging

Navigate

Submit an Article

Research Paper|Volume 15, Issue 17|pp. 8664–8691

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy

Back to articleFigure 4(4 of 8)

100%

Figure 4.Co-expression of KIAA1429 and immune-related genes. *P < 0.05, **P < 0.01, ***P < 0.001.